Key Market Indicator:
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Tue, 19.09.2023
Diversified Energy PLC
First Berlin Equity Research has published a research update on Diversified
Energy PLC (ISIN: GB00BYX7JT74). Analyst Simon Scholes reiterated his BUY
rating and maintained his GBp 180.00 price target.
Abstract:
H1/23 results once again demonstrated the effectiveness of DEC's business
model in delivering high profits irrespective of the level of [ … ]
Mon, 18.09.2023
PAION AG
First Berlin Equity Research has published a research update on PAION AG
(ISIN: DE000A0B65S3). Analyst Simon Scholes reiterated his BUY rating and
decreased the price target from EUR 38.00 to EUR 11.00.
Abstract:
PAION's lead product remimazolam was first approved in January 2020 in
Japan in the indication general anesthesia (GA). It has since [ … ]
Mon, 18.09.2023
Haemato AG
First Berlin Equity Research hat ein Research Update zu Haemato AG (ISIN:
DE000A289VV1) veröffentlicht. Analyst Ellis Acklin bestätigt seine
BUY-Empfehlung und erhöht das Kursziel von EUR 33,00 auf EUR 34,00.
Zusammenfassung:
Das Sechsmonatsbericht lag nahe an unseren Prognosen und verdeutlichte die
schlankere operative Kostenstr [ … ]
Thu, 14.09.2023
HAEMATO AG
H1 2023: Turnover and EBIT above our expectations; forecasts and target
price slightly raised; BUY rating confirmed
In the first half of 2023, HAEMATO AG achieved a revenue increase of 10.5 %
to € 133.64 million (previous year: € 120.97 million) and thus exceeded our
expectations. This sales development, which is separated accord [ … ]
Thu, 14.09.2023
Vectron Systems AG
H1 2023: 'On track': Turnover in line with expectations; EBITDA climbs
significantly; GBC-Forecasts raised; Target price raised to €10.00
(previously: €9.40); Rating: BUY
The first six months of 2023 were marked by the consolidation of acardo
group AG, which was acquired on 1st January 2023. acardo sales, which were
consolidated [ … ]
Tue, 12.09.2023
Media & Games Invest SE
First Berlin Equity Research hat ein Research Update zu Media and Games
Invest SE (ISIN: SE0018538068) veröffentlicht. Analyst Ellis Acklin
bestätigt seine BUY-Empfehlung und senkt das Kursziel von EUR 4,00 auf EUR
3,20.
Zusammenfassung:
Die Auswirkungen der schwachen Werbeausgaben standen im Mittelpunkt des
Sechsmonatsberichts. Das w [ … ]
Mon, 11.09.2023
Media and Games Invest SE
HY1 2023: Solid sales development despite economic headwinds; stable
operating earnings development due to strict cost management; GBC estimates
and price target adjusted after guidance reduction
Business development in HY1 2023
Media and Games Invest SE (MGI) published its half-year figures for the
current financial year on 31 Augu [ … ]
Wed, 06.09.2023
Knaus Tabbert AG
First Berlin Equity Research hat ein Research Update zu Knaus Tabbert AG
(ISIN: DE000A2YN504) veröffentlicht. Analyst Ellis Acklin bestätigt seine
BUY-Empfehlung und bestätigt sein Kursziel von EUR 83,00.
Zusammenfassung:
Wir haben den Caravan Salon 2023 in Düsseldorf besucht, um die neuesten
Wohnmobile aus erster Hand zu se [ … ]
Mon, 04.09.2023
Aroundtown SA
First Berlin Equity Research hat ein Research Update zu Aroundtown SA
(ISIN: LU1673108939) veröffentlicht. Analyst Ellis Acklin bestätigt seine
BUY-Empfehlung und bestätigt sein Kursziel von EUR 3,50.
Zusammenfassung:
AT ist in einem Jahr mit Gegenwind auf einem stabilen Weg geblieben und
konnte in Q2 die gute operative Leistung [ … ]
Wed, 30.08.2023
Cardiol Therapeutics Inc
First Berlin Equity Research has published a research update on Cardiol
Therapeutics Inc. (ISIN: CA14161Y2006). Analyst Christian Orquera
reiterated his BUY rating and maintained his USD 3.60 price target.
Abstract:
Cardiol Therapeutics has published its H1 2023 financial report. Overall
figures were in line with our expectations. The company r [ … ]